Home Podcasts EuroIntervention | Editor's Choice
EuroIntervention | Editor's Choice

EuroIntervention | Editor's Choice

EuroIntervention 6 Episodes Oct 15, 2026

EuroIntervention | Editor's Choice is a podcast by EuroIntervention that highlights the latest research in interventional cardiology. Host Aaysha Cader interviews authors to explore study designs, key findings, and their relevance in contemporary practice.

Episodes

Safety and Effectiveness of the Vertex Pulmonary Embolectomy System in Acute Intermediate-Risk Pulmonary Embolism: SPIRARE II Pivotal Trial
Safety and Effectiveness of the Vertex Pulmonary Embolectomy System in Acute Intermediate-Risk Pulmonary Embolism: SPIRARE II Pivotal Trial Oct 15, 2026 14:06 In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Catalin Toma dive into the findings of SPIRARE II. Dr Toma shares the strategy behind enriching the trial's design; core efficacy and safety endpoint results (RV/LV ratio & MAE rates); the mechanics and potential advantages of the Vertex technology; and future clinical horizons for mechanical thrombectomy. Hosted on Acast. See acas
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk - The SELUTION DeNovo HBR sub-study
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk - The SELUTION DeNovo HBR sub-study Oct 5, 2026 15:54 In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Philip Urban discuss the findings of SELUTION DeNovo HBR, comparing SEB versus DES PCI strategies. Dr Urban describes the dual-risk profile of the enrolled HBR patients and shares the hypothesis-generating results including 1-year TVF, BARC 3+ bleeding, and NACE rates which favoured the balloon arm – possibly linked to lower use of antipla
Phenotypes of cardiogenic shock after out-of-hospital cardiac arrest: the SCAI-V classification: Original Research
Phenotypes of cardiogenic shock after out-of-hospital cardiac arrest: the SCAI-V classification: Original Research Sep 24, 2026 17:07 In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Nilesh Pareek discuss the SCAI-V classification for cardiogenic shock in OHCA patients. Dr Pareek explains how both haemodynamic status and lactate thresholds are incorporated into a 2x2 factorial design, describes the surprising finding of higher mortality in the systemic ischaemia group versus the haemodynamic shock group, and compares t
Reduced-dose direct oral anticoagulant versus antiplatelet strategies after left atrial appendage occlusion: Original Research
Reduced-dose direct oral anticoagulant versus antiplatelet strategies after left atrial appendage occlusion: Original Research Sep 9, 2026 21:16 In this episode of Editor’s Choice, Dr Aaysha Cader and Professor Gregory Lip compare the post-LAAO clinical outcomes of low-dose DOAC, DAPT, and SAPT, based on data from the TriNetX Global Network.With limited guideline recommendations currently in place, Professor Lip summarises the findings of the comparisons; he explains why, mechanistically, reduced-dose DOAC might be preferable to antiplatel
Long-Term Outcomes of High-Risk Plaques with Negative FFR: The PECTUS-obs Study
Long-Term Outcomes of High-Risk Plaques with Negative FFR: The PECTUS-obs Study Aug 26, 2026 16:34 In this episode of Editor's Choice, Dr Aaysha Cader speaks with Professor Niels van Royen and Doctor Rick Volleberg about the findings of the PECTUS-obs study.They discuss the association between high-risk plaque and an approximately twofold increase in 5-year MACE; plaque rupture as a marker of both local and systemic vulnerability; and why combining imaging and physiology may be key to managing
Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial: Original Research
Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial: Original Research Jul 5, 2026 13:22 In this episode of Editor's Choice, Dr Aaysha Cader speaks with Professor Huimin Chu about LAAC with AnchorMan versus Watchman 2.5 devices.They discuss how the 12-month results of the SAFE-PROTECT trial indicated the non-inferiority of the novel AnchorMan occluder for both primary and secondary endpoints: clinical success and LAA closure success at 1 year. This study found that the AnchorMan’s des
Door-to-unload time and mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock: Original Research
Door-to-unload time and mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock: Original Research Jun 17, 2026 18:26 In this episode of Editor's Choice, Doctor Aaysha Cader speaks with Doctor Shin Nagai and Professor Toyoaki Murohara about the connection between door-to-unload time and mortality in STEMI-CS patients.They discuss how the J-PVAD registry data confirm that early unloading and prompt revascularisation are paramount; as high-volume centres achieve these targets more consistently, organised shock syst
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios: State-of-the-Art
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios: State-of-the-Art Jun 1, 2026 16:02 In this episode of Editor's Choice, Doctor Aaysha Cader speaks with Professor Giuseppe Tarantini about the current state-of-the-art on TAVI and coronary interventions, recently published in EuroIntervention.Professor Tarantini shares insights on managing the complex interaction between CAD, PCI, and TAVI; the value of CT imaging and angiography in strategy planning; and how to optimise outcomes in
Glucocorticoids to reduce PPI after TAVI: the GLUCO-TAVI randomised trial: Original Research
Glucocorticoids to reduce PPI after TAVI: the GLUCO-TAVI randomised trial: Original Research May 15, 2026 15:17 In this episode of Editor’s Choice, Dr Aaysha Cader speaks with Dr Juan Miguel Ruiz-Nodar about the results of the GLUCO-TAVI trial, recently published in EuroIntervention.They discuss the impact of glucocorticoid therapy on reducing permanent pacemaker implantation (PPI) following TAVI, highlighting a 50% relative risk reduction at one month. Dr Ruiz-Nodar also shares insights into the mechanisms
QFR versus FFR in the 2-year follow-up of FAVOR III Europe: Original Research
QFR versus FFR in the 2-year follow-up of FAVOR III Europe: Original Research May 6, 2026 15:13 In this episode of Editor’s Choice, Dr Aaysha Cader speaks with Doctor Birgitte Andersen about the latest findings from the FAVOR III Europe trial, recently published in EuroIntervention.They discuss the 2-year follow-up comparing quantitative flow ratio (QFR) and fractional flow reserve (FFR), including the key outcome that QFR did not demonstrate non-inferiority at one year. Dr Andersen explores
The ELASTA-T technique: Expert Review
The ELASTA-T technique: Expert Review Apr 27, 2026 15:48 In this episode of Editor’s Choice, Dr Aaysha Cader speaks with Professor Michael Joner about the ELASTA-T technique, presented in the Expert Review, “Electrosurgical Laceration and Stabilisation of Tricuspid Edge-to-Edge Repair: the ELASTA-T Technique,” recently published in EuroIntervention.Professor Joner explains the clinical rationale behind ELASTA-T and its potential role in the evolving tre
High ischaemic risk criteria in CCS patients undergoing PCI: Original Research
High ischaemic risk criteria in CCS patients undergoing PCI: Original Research Apr 13, 2026 12:54 In this episode of Editor’s Choice, Professor Roxana Mehran discusses her original research article, “Prevalence and Prognostic Impact of High Ischaemic Risk Criteria in Chronic Coronary Syndrome Patients Undergoing PCI,” recently published in EuroIntervention. In conversation with Dr Aaysha Cader, Professor Mehran explores the background, methodology, and key findings from this study conducted

Recommended